Transaction · 0001628280-26-060234

Gold Kelly

Gold Kelly, CFO, reported an open-market or private purchase at Camp4 Therapeutics Corp involving 10000.000000 shares for an estimated $39600.00. Reported holdings after the transaction were 10000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCFO
CAMPCamp4 Therapeutics Corp
Trade date
Aug 31, 2026
Filing date
Sep 02, 2026
View on SEC Insider profile
Estimated value$39.6kShares × reported price
Shares traded10.0k$3.96 per share
Holdings after10.0kIndirect · By Spouse
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

New position: there is no prior reported position to use as a percentage baseline.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CAMP price since this filing

Daily closing prices, with the filing date and available return windows
CAMP · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -9.2%1w ago +13.7%1d ago +9.2%
Returns since7d +13.9%30d +5.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001628280-26-060234
Common Stock
Transaction date
Aug 31, 2026
Filed Sep 02, 2026, 11:50 PM · 2d delay
Shares
10,000 sh
$3.96 per share
Estimated value
$39.6k
Computed from shares × price
Holdings after
10,000 sh
Indirect · By Spouse

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
CFO Buy Large Holdings Increase
Filing-only score

+34 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • cfo_buy+10 points

    is_officer + officer_title/role mentions CFO

    CFO open-market purchase.
  • large_holdings_increase+8 points

    large-holdings-increase signal matched

    Reported acquired shares meet the configured percentage of post-transaction holdings.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The shares reported herein were purchased in the open market in multiple transactions at prices ranging from $3.88 to $4.00, inclusive. The price reported in Column 4 is a weighted average price. The…

  2. F2

    The shares reported herein are held in a brokerage account in the name of David Gold, the Reporting Person's spouse. The Reporting Person does not exercise investment control over this account. The Re…

  3. F3

    Includes 2,039 shares previously acquired by the reporting person pursuant to the CAMP4 Therapeutics Corporation Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 1…

Original filing · 0001628280-26-060234
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CAMP